The statements below are read from Hemant Surgical Industries Ltd’s filed results, 3 filed quarters and 2 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: H2 FY25-26 · filed May 16, 2026 · audited
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | H2 FY25Mar 2025 | H1 FY26Sep 2025 | H2 FY26Mar 2026Latest | YoYlatest |
|---|---|---|---|---|
| Sales | 57.8 | 64.6 | 167 | +189.4% |
| 52.3 | 57.0 | 152 | +189.8% | |
| Operating profit | 5.45 | 7.65 | 15.6 | +185.7% |
| OPM % | 9.4% | 11.8% | 9.3% | -0.1 pp |
| Other income | 2.71 | 2.33 | 3.53 | +30.1% |
| Interest | 1.43 | 1.95 | 2.01 | +40.3% |
| Depreciation | 0.74 | 0.74 | 0.80 | +7.6% |
| Profit before tax | 5.99 | 7.30 | 16.3 | +172.1% |
| Tax % | 18.9% | 25.2% | 21.8% | +3.0 pp |
| Net profit | 4.86 | 5.46 | 12.7 | +162.0% |
| EPS (₹) | 4.65 | 5.15 | 10.24 | +120.2% |
No results filing with a recorded time yet — reactions appear from the first quarter whose announcement we timestamped (May 2026 onward), on the session the market could trade it.
